| 2026-07-09 | Press release | 07-09-2026 - ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months |
| 2026-06-11 | Press release | Download PDF |
| 2026-06-11 | Proxy statement | Proxy Statement |
| 2026-05-15 | Presentation | Download PDF |
| 2026-05-15 | Earnings deck | Earnings Presentation |
| 2026-05-14 | Press release | 05-14-2026 - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 |
| 2026-05-07 | Press release | 05-07-26 - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 |
| 2026-04-13 | Press release | 04-13-26 - ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors |
| 2026-04-08 | Press release | 04-08-26 – ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results |
| 2026-03-18 | Press release | 03-18-26 ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board |
| 2026-03-04 | Press release | 03-04-26 ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 |
| 2026-02-18 | Press release | 02-18-26 ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 |
| 2026-01-08 | Press release | 01-08-26 ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 |
| 2026-01-07 | Press release | 01-07-26 ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus |
| 2025-12-24 | Press release | 12-24-25 – ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® |
| 2025-11-13 | Press release | 11-13-25 – ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025 |
| 2025-11-06 | Press release | 11-06-25 – ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 |
| 2025-10-07 | Press release | 10-07-25 – ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025 |
| 2025-09-29 | Press release | 09-29-25 – ImmuCell Announces Selection of its Next President and CEO |
| 2025-08-14 | Press release | 08-14-25 – ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025 |
| 2025-08-12 | Press release | 08-12-25 – ImmuCell Announces Bank Debt Refinancing |
| 2025-08-07 | Press release | 08-07-25 – ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025 |
| 2025-07-09 | Press release | 07-09-25 – ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025 |
| 2025-06-25 | Press release | 06-25-25 – ImmuCell Embarks on CEO Succession Planning Process |
| 2025-06-05 | Press release | 06-05-25 – ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders |
| 2025-05-14 | Press release | 05-14-25 – ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025 |
| 2025-05-12 | Press release | 05-12-25 – ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 |
| 2025-04-08 | Press release | 04-08-25 – ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 |
| 2025-04-07 | Press release | 04-07-25 – ImmuCell Hires Chief Financial Officer |
| 2025-04-02 | Press release | 04-02-25 – ImmuCell Announces Initiation of Investigational Product Use of Re-Tain® |
| 2025-02-25 | Press release | 02-25-25 – ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 |
| 2025-02-20 | Press release | 02-20-25 – ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 |
| 2025-01-16 | Press release | 01-16-25 – ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses |
| 2025-01-09 | Press release | 01-09-25 – ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024 |
| 2024-11-13 | Press release | 11-13-24 – ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 |
| 2024-11-07 | Press release | 11-07-24 – ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 |
| 2024-10-08 | Press release | 10-08-24 – ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 |
| 2024-08-13 | Press release | 08-13-24 – ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 |
| 2024-08-07 | Press release | 08-07-24 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 |
| 2024-07-09 | Press release | 07-09-24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 |